Evidence map›Paper›PMID 38098664›Full record

ArticleFrontiers in microbiology2023

Soft rot pathogen

Marcin Borowicz, Dorota M Krzyżanowska, Magdalena Narajczyk, Marta Sobolewska, Magdalena Rajewska, Paulina Czaplewska, Katarzyna Węgrzyn, Robert Czajkowski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Genome Evolution in Plant Pathogenic Bacteria.Genome biology and evolution · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Beyond kin killing:ISME communications · 2026
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marcin BorowiczLaboratory of Biologically Active Compounds, Intercollegiate Faculty of Biotechnology of UG and MUG, University of Gdańsk, Gdańsk, Poland.
Dorota M KrzyżanowskaLaboratory of Biologically Active Compounds, Intercollegiate Faculty of Biotechnology of UG and MUG, University of Gdańsk, Gdańsk, Poland.
Magdalena NarajczykBioimaging Laboratory, Faculty of Biology, University of Gdańsk, Gdańsk, Poland.
Marta SobolewskaLaboratory of Biologically Active Compounds, Intercollegiate Faculty of Biotechnology of UG and MUG, University of Gdańsk, Gdańsk, Poland.
Magdalena RajewskaLaboratory of Plant Microbiology, Intercollegiate Faculty of Biotechnology of UG and MUG, University of Gdańsk, Gdańsk, Poland.
Paulina CzaplewskaLaboratory of Mass Spectrometry-Core Facility Laboratories, Intercollegiate Faculty of Biotechnology of UG and MUG, University of Gdańsk, Gdańsk, Poland.
Katarzyna WęgrzynLaboratory of Molecular Biology, Intercollegiate Faculty of Biotechnology of UG and MUG, University of Gdańsk, Gdańsk, Poland.
Robert CzajkowskiLaboratory of Biologically Active Compounds, Intercollegiate Faculty of Biotechnology of UG and MUG, University of Gdańsk, Gdańsk, Poland.
University of Gdańsk · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tailocins are nanomolecular machines with bactericidal activity. They are produced by bacteria to contribute to fitness in mixed communities, and hence, they play a critical role in their ecology in a variety of habitats. Here, we characterized the new tailocin produced by

Indexed as

bacteria-bacteria interactionsbacteriocinbacteriophageCaenorhabditis elegansErwinia chrysanthemiphage tailtailocin

Identifiers

PMID38098664
PMCPMC10719855
OpenAlexW4389200801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.